drugset / Trial / NCT00065169
Delaying Alzheimer Disease Symptoms With Anti-Inflammatory Drugs
Completed
138 enrolled
University of California, Los Angeles
National Institute of Mental Health (NIMH) · collab
RandomizedParallel-groupDouble-blindPrevention
Summary
The purpose of this study is to determine whether the anti-inflammatory drug celecoxib can delay the onset of Alzheimer Disease (AD) in people with Age Associated Memory Impairment (AAMI). This study will also evaluate genetic risk and brain structure as potential predictors of mental decline.
Timeline
- Start
- 2000-11
- Primary completion
- 2005-11
- Completion
- 2005-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Celecoxib | Other / unclassified | — | — |